- Home
- AXR vs INBX Comparison
AXR vs INBX Comparison
Compare AXR & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- INBX
- Stock Information
- Founded
- AXR 1961
- INBX 2010
- Country
- AXR United States
- INBX United States
- Employees
- AXR N/A
- INBX N/A
- Industry
- AXR Homebuilding
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- AXR Real Estate
- INBX Health Care
- Exchange
- AXR Nasdaq
- INBX Nasdaq
- Market Cap
- AXR 203.2M
- INBX 218.9M
- IPO Year
- AXR N/A
- INBX 2020
- Fundamental
- Price
- AXR $33.31
- INBX $14.86
- Analyst Decision
- AXR
- INBX Hold
- Analyst Count
- AXR 0
- INBX 1
- Target Price
- AXR N/A
- INBX N/A
- AVG Volume (30 Days)
- AXR 26.7K
- INBX 71.2K
- Earning Date
- AXR 12-24-2024
- INBX 11-14-2024
- Dividend Yield
- AXR N/A
- INBX N/A
- EPS Growth
- AXR N/A
- INBX N/A
- EPS
- AXR 2.30
- INBX 119.38
- Revenue
- AXR $63,223,000.00
- INBX $1,568,000.00
- Revenue This Year
- AXR N/A
- INBX N/A
- Revenue Next Year
- AXR N/A
- INBX N/A
- P/E Ratio
- AXR $14.07
- INBX $0.12
- Revenue Growth
- AXR 54.34
- INBX 19.24
- 52 Week Low
- AXR $15.88
- INBX $10.80
- 52 Week High
- AXR $39.67
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- AXR 42.00
- INBX 52.04
- Support Level
- AXR $31.39
- INBX $14.19
- Resistance Level
- AXR $36.80
- INBX $15.22
- Average True Range (ATR)
- AXR 1.76
- INBX 0.66
- MACD
- AXR -0.74
- INBX 0.00
- Stochastic Oscillator
- AXR 13.89
- INBX 49.13
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.